| Acne |
1 |
1 |
| Food and Drug Administration (FDA) |
0 |
0.75 |
| Rosacea |
0 |
0.69 |
| Isotretinoin |
0 |
0.65 |
| Pregnancy |
0 |
0.18 |
| Patient Safety |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.09 |
| Risk Evaluation and Mitigation Strategies |
0 |
0.09 |
| Skin and Soft Tissue Infection |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.09 |
| Transgender |
0 |
0.09 |